Cited by 218Hepatitis B Virus StudiesGut microbiota and healthLiver physiology and pathology

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota

Open access

Chou, Han-Hsuan, Chien, Wei-Hung, Wu, Li-Ling, Cheng, Chi-Hung, Chung, Chen-Han, Horng, Jau-Haw, Ni, Yen-Hsuan, Tseng, Hong-Tai, Wu, Dafei, Lu, Xuemei, Wang, Hurng-Yi, Chen, Pei-Jer, Chen, Ding-Shinn·2015·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1424775112PMC PMC4343154

Open this paper in CoChat — free account

Abstract

Significance: Ninety-five percent of adult-acquired infections lead to spontaneous clearance, whereas >90% of exposed neonates and ∼30% of children aged 1–5 y fail to resolve hepatitis B virus (HBV) and develop chronic infection. A strong, diverse, adaptive immune response is considered essential for HBV clearance, but the mechanisms to generate a favorable response remain elusive. Here, we show that, while 12-wk-old C3H/HeN mice cleared HBV within 6 wk postinjection (wpi), their 6-wk-old counterparts remained HBV-positive at 26 wpi. Sterilization of gut microbiota from 6 to 12 wk of age using antibiotics prevented mice from rapidly clearing HBV. This model is valuable to the study of liver tolerance and enables the investigation of the mechanisms involved in effective control of HBV.

Integrity signals

Registry

Crossref · 10.1073/pnas.1424775112

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., Wei, D., Goldfarb, K. C., Santee, C. A., Lynch, S. V., et al. (2009) · Cell · doi:10.1016/j.cell.2009.09.033 · Cited by 4,554
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952
Hepatitis B Virus Infection — Natural History and Clinical Consequences
Ganem, D., & Prince, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031087 · Cited by 2,361
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219
Hepatitis B: The virus and disease #
Liang, J. T. (2009) · Hepatology · doi:10.1002/hep.22881 · Cited by 1,066
Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance
Limmer, A., Ohl, J., Kurts, C., Ljunggren, H.-G., Reiss, Y., Groettrup, M., Momburg, F., Arnold, B., & Knolle, P. A. (2000) · Nature Medicine · doi:10.1038/82161 · Cited by 758 · cited 1×
“Liver sinusoid endothelial cells (LSECs) respond to Gram-negative bacteria-derived lipopolysaccharides (LPSs) through Toll-like receptor (TLR) 4 by the secretion of interleukin-10 (IL-10), which induces T-cell tolerance (17, 18).”
Background
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
Milich, D. R., Jones, J. E., Hughes, J. L., Price, J. A., Raney, A. K., & McLachlan, A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6599 · Cited by 580
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
Kamatani, Y., Wattanapokayakit, S., Ochi, H., Kawaguchi, T., Takahashi, A., Hosono, N., Kubo, M., Tsunoda, T., Kamatani, N., Kumada, H., et al. (2009) · Nature Genetics · doi:10.1038/ng.348 · Cited by 514
Tolerance of Infections
Ayres, J. S., & Schneider, D. S. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075030 · Cited by 475

Show all 34 references

Sorted by citations

The gut microbiome and liver cancer: mechanisms and clinical translation
Yu, L.-X., & Schwabe, R. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.72 · Cited by 634
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature
Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., Lekic, N., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020395 · Cited by 551
Gut microbiome, liver immunology, and liver diseases
Wang, R., Tang, R., Li, B., Ma, X., Schnabl, B., & Tilg, H. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00592-6 · Cited by 466
Gut–liver axis: barriers and functional circuits
Pabst, O., Hornef, M. W., Schaap, F. G., Cerovic, V., Clavel, T., & Bruns, T. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00771-6 · Cited by 488
Factors Influencing the Gut Microbiota, Inflammation, and Type 2 Diabetes
Li, W., & Duffy, A. J. (2017) · Journal of Nutrition · doi:10.3945/jn.116.240754 · Cited by 433
Interaction of the microbiota with the human body in health and diseases
Altveş, S., Yıldız, H. K., & Vural, H. C. (2019) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.19-023 · Cited by 398
Gut microbiome in HCC – Mechanisms, diagnosis and therapy
Schwabe, R. F., & Greten, T. F. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.016 · Cited by 375
The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis
Erttmann, S. F., Swacha, P., Aung, K. M., Brindefalk, B., Jiang, H., Härtlová, A., Uhlin, B. E., Wai, S. N., & Gekara, N. O. (2022) · Immunity · doi:10.1016/j.immuni.2022.04.006 · Cited by 358
Microbes and Cancer
Dzutsev, A., Badger, J. H., Perez-Chanona, E., Roy, S., Salcedo, R., Smith, C. K., & Trinchieri, G. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052133 · Cited by 302
The Commensal Microbiota and Viral Infection: A Comprehensive Review
Li, N., Ma, W., Pang, M., Fan, Q., & Hua, J.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01551 · Cited by 290
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 271
Paradigms of Lung Microbiota Functions in Health and Disease, Particularly, in Asthma
Mathieu, E., Escribano-Vázquez, U., Descamps, D., Cherbuy, C., Langella, P., Riffault, S., Rémot, A., & Thomas, M. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01168 · Cited by 241
Mechanisms of Hepatitis B Virus Persistence
Tsai, K.-N., Kuo, C.-F., & Ou, J. J. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.07.006 · Cited by 207
The Intestinal Microbiome Restricts Alphavirus Infection and Dissemination through a Bile Acid-Type I IFN Signaling Axis
Winkler, E. S., Shrihari, S., Hykes, B. L., Handley, S. A., Andhey, P. S., Huang, Y. S., Swain, A., Droit, L., Chebrolu, K. K., Mack, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.029 · Cited by 190
Hepatitis B virus persistence and reactivation
Shi, Y., & Zheng, M. (2020) · BMJ · doi:10.1136/bmj.m2200 · Cited by 198
Fecal microbiota transplantation induces hepatitis B virus e‐antigen (HBeAg) clearance in patients with positive HBeAg after long‐term antiviral therapy
Ren, Y., Ye, Z., Yang, L., Jin, L., Wei, W., Deng, Y., Chen, X., Xiao, C., Yu, X., Xu, H., et al. (2016) · Hepatology · doi:10.1002/hep.29008 · Cited by 173
Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
Fiebiger, U., Bereswill, S., & Heimesaat, M. M. (2016) · European Journal of Microbiology and Immunology · doi:10.1556/1886.2016.00036 · Cited by 165
Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases
Biazzo, M., & Deidda, G. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11144119 · Cited by 172
Role of gut microbiota in liver disease
Albhaisi, S. A. M., Bajaj, J. S., & Sanyal, A. J. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00118.2019 · Cited by 155
Facing a new challenge
Zhang, S., & Chen, D. (2019) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000245 · Cited by 150
Self-citation
Role of Gut Microbiota in Hepatocarcinogenesis
Gupta, H., Youn, G. S., Shin, M. J., & Suk, K. T. (2019) · Microorganisms · doi:10.3390/microorganisms7050121 · Cited by 134
A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature
Giuffrè, M., Campigotto, M., Campisciano, G., Comar, M., & Crocè, L. S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2019 · Cited by 122
Cell and Animal Models for Studying Hepatitis B Virus Infection and Drug Development
Hu, J., Lin, Y., Chen, P., Watashi, K., & Wakita, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.093 · Cited by 127
Self-citation
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection
Rehermann, B., & Thimme, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.061 · Cited by 109
The regulation of host defences to infection by the microbiota
Brown, R. L., & Clarke, T. B. (2016) · Immunology · doi:10.1111/imm.12634 · Cited by 106
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response
Shen, Y., Wu, S., Chen, Y., Li, X., Zhu, Q., Nakayama, K., Zhang, W., Weng, C., Zhang, J., Wang, H., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2155018 · Cited by 103
Self-citation
Decreased Diversity of the Oral Microbiota of Patients with Hepatitis B Virus-Induced Chronic Liver Disease: A Pilot Project
Ling, Z., Liu, X., Cheng, Y., Jiang, X., Jiang, H., Wang, Y., & Li, L. (2015) · Scientific Reports · doi:10.1038/srep17098 · Cited by 103
Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents
Tokuhara, D. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.700058 · Cited by 106
Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease
Chen, Z., Xie, Y., Zhou, F., Zhang, B., Wu, J., Yang, L., Xu, S., Stedtfeld, R. D., Chen, Q., Liu, J., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00383 · Cited by 100
Hepatocytes as Immunological Agents
Crispe, I. N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501668 · Cited by 102
Natural history of chronic hepatitis B virus infection from infancy to adult life -the mechanism of inflammation triggering and long-term impacts
Wu, J., & Chang, M. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0199-y · Cited by 88
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
Jiang, J., Chen, X., Ren, Z., & Zheng, S. (2018) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2018.11.002 · Cited by 100
HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA
Yan, Z., Zeng, J., Yu, Y., Xiang, K., Hu, H., Zhou, X., Gu, L., Wang, L., Zhao, J., Young, J. A. T., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.004 · Cited by 80
Relationship between intestinal microbial dysbiosis and primary liver cancer
Zhang, L., Wu, Y.-N., Chen, T., Ren, C.-H., Li, X., & Liu, G. (2019) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2019.01.002 · Cited by 80
Role of the microbiome in non-gastrointestinal cancers
Pevsner‐Fischer, M., Tuganbaev, T., Meijer, M. T., Zhang, S., Zeng, Z., Chen, M., & Elinav, E. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i2.200 · Cited by 72
Inhibition of hepatitis B virus replication via HBV DNA cleavage by Cas9 from Staphylococcus aureus
Liu, Y., Zhao, M., Gong, M., Xu, Y., Xie, C., Deng, H., Li, X., Wu, H., & Wang, Z. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.02.011 · Cited by 71
Detection of the hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice transduced with a recombinant AAV-HBV vector
Lucifora, J., Salvetti, A., Marniquet, X., Mailly, L., Testoni, B., Fusil, F., Inchauspé, A., Michelet, M., Michel, M., Levrero, M., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.07.006 · Cited by 69
Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
Joshi, S. S., & Coffin, C. S. (2020) · Hepatology Communications · doi:10.1002/hep4.1460 · Cited by 69
Fecal Microbiota Transplantation in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients: A Pilot Study
Chauhan, A. K., Kumar, R. K., Sharma, S., Mahanta, M., Vayuuru, S. K., Nayak, B., Kumar, S., & Shalimar, S. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06246-x · Cited by 70
In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application
Du, Y., Broering, R., Li, X., Zhang, X., Liu, J., Yang, D., & Lu, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.766534 · Cited by 58
The Immunologic Role of Gut Microbiota in Patients with Chronic HBV Infection
Yang, R., Yao, X., Dai, Z., Lin, X., & Wang, H. (2018) · Journal of Immunology Research · doi:10.1155/2018/2361963 · Cited by 56
Self-citation
Hepatitis B Virus Infection Alters Gut Microbiota Composition in Mice
Zhu, Q., Xia, P., Zhou, X., Li, X., Guo, W., Zhu, B., Zheng, X., Wang, B., Yang, D., & Wang, J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00377 · Cited by 58
Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy
Kang, Y., & Cai, Y. (2017) · Journal of Hospital Infection · doi:10.1016/j.jhin.2017.04.007 · Cited by 55
Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites
Fu, Z. D., & Cui, J. Y. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0087-0 · Cited by 54
Advances in Gut Microbiota of Viral Hepatitis Cirrhosis
Wang, Y., Pan, C. Q., & Xing, H. (2019) · BioMed Research International · doi:10.1155/2019/9726786 · Cited by 52
Depletion of Gut Microbiota Impairs Gut Barrier Function and Antiviral Immune Defense in the Liver
Guo, W., Zhou, X., Li, X., Zhu, Q., Peng, J., Zhu, B., Zheng, X., Lu, Y., Yang, D., Wang, B., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636803 · Cited by 55
The intestinal microbial metabolite nicotinamide n-oxide prevents herpes simplex encephalitis via activating mitophagy in microglia
Li, F., Wang, Y., Song, X., Wang, Z., Jia, J., Qing, S., Huang, L., Wang, S., Wang, S., Ren, Z., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2096989 · Cited by 53
Interplay between viruses and bacterial microbiota in cancer development
Vyshenska, D., Lam, K. C., Shulzhenko, N., & Morgun, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.05.003 · Cited by 49
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Rodrigues, S. G., der Merwe, V., Krag, A. A., & Wiest, R. (2024) · Seminars in Immunology · doi:10.1016/j.smim.2023.101859 · Cited by 51
Oral microbial community analysis of the patients in the progression of liver cancer
Li, D., Xi, W., Zhang, Z., Ren, L., Deng, C., Chen, J., Sun, C., Zhang, N., & Xu, J. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104479 · Cited by 52
A long-distance relationship: the commensal gut microbiota and systemic viruses
Winkler, E. S., & Thackray, L. B. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.05.009 · Cited by 51
Gut microbiota and the development of pediatric diseases
Lu, C., & Ni, Y. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1082-z · Cited by 50
Self-citation
Hepatitis B virus persistence in mice reveals IL-21 and IL-33 as regulators of viral clearance
Shen, Z., Yang, H., Yang, S., Wang, W., Cui, X., Zhou, X., Liu, W., Pan, S., Liu, Y., Zhang, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02304-7 · Cited by 50
Probiotics reduce postoperative infections in patients undergoing colorectal surgery: A systematic review and meta-analysis
Liu, P. C., Yan, Y. K., Ma, Y. J., Wang, X. W., Geng, J., Wang, M. C., Wei, F. X., Zhang, Y. W., Xu, X. D., & Zhang, Y. C. (2017) · Gastroenterology Research and Practice · doi:10.1155/2017/6029075 · Cited by 49
Entecavir therapy reverses gut microbiota dysbiosis induced by hepatitis B virus infection in a mouse model
Li, X., Wu, S., Du, Y., Yang, L., Li, Y., & Hong, B. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106000 · Cited by 47
Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure
Chang, J., & Guo, J. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.07.006 · Cited by 48
Farnesoid X receptor‐α is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo
Mouzannar, K., Fusil, F., Lacombe, B., Ollivier, A., Ménard, C., Lotteau, V., Cosset, F., Ramière, C., & André, P. (2018) · The FASEB Journal · doi:10.1096/fj.201801181r · Cited by 42
Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction
Lechner, S., Yee, M. F., Limketkai, B. N., & Pham, E. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06100-0 · Cited by 42
Microbiome Big-Data Mining and Applications Using Single-Cell Technologies and Metagenomics Approaches Toward Precision Medicine
Cheng, M., Cao, L., & Ning, K. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00972 · Cited by 42
Mechanisms of hepatocellular carcinoma and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
Zhang, S., Mak, L., Yuen, M., & Seto, W. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2024.0837 · Cited by 41
Immunopathogenesis of HBV Infection
Wu, J., Han, M., Li, J., Yang, X., & Yang, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9151-4_4 · Cited by 40
A review: Roles of carbohydrates in human diseases through regulation of imbalanced intestinal microbiota
Cheng, X., Zheng, J., Lin, A., Xia, H., Zhang, Z., Gao, Q., Lv, W., & Liu, H. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104197 · Cited by 44
Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice
Wu, L., Peng, W., Wu, H., Miaw, S., Yeh, S., Yang, H., Liao, P.-H., Lin, J., Chen, Y., Hong, Y., et al. (2019) · Hepatology · doi:10.1002/hep.30510 · Cited by 40
Self-citation
Intestinal Microbiota—A Promising Target for Antiviral Therapy?
Yang, M., Yang, Y., He, Q., Zhu, P., Liu, M., Xu, J., & Zhao, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.676232 · Cited by 41
The Immune System and Its Contribution to Variability in Regenerative Medicine
Moore, E., Maestas, D. R., Comeau, H. Y., & Elisseeff, J. H. (2020) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0335 · Cited by 37
Research Progress of Fecal Microbiota Transplantation in Liver Diseases
Zhao, Y., Chen, G., Xu, J., Chen, D., Yang, B., Chen, Z., & Wei, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041683 · Cited by 38
Self-citation
T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model
Sang, X., Wang, R., Han, Y., Zhang, C., Shen, H., Yang, Z., Xiong, Y., Liu, H., Liu, S., Li, R., et al. (2017) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2017.02.005 · Cited by 37
PGLYRP2 drives hepatocyte-intrinsic innate immunity by trapping and clearing hepatitis B virus
Li, Y., Ma, H., Zhang, Y., He, T., Li, B., Ren, H., Feng, J. F., Sheng, J., Li, K., Yu, Q., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188083 · Cited by 36
Gut microbiota modulate the immune effect against hepatitis B virus infection
Xu, D., Huang, Y., & Wang, J. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-015-2464-0 · Cited by 36
Bifidobacterium longum BL-10 with Antioxidant Capacity Ameliorates Lipopolysaccharide-Induced Acute Liver Injury in Mice by the Nuclear Factor-κB Pathway
Dong, J., Ping, L., Meng, Y., Zhang, K., Tang, H., Liu, D., Li, B., & Huo, G. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c02950 · Cited by 36
Comparative analysis of the fecal microbiota from different species of domesticated and wild suids
Correa‐Fiz, F., Blanco-Fuertes, M., Navas, M. J., Lacasta, A., Bishop, R. P., Githaka, N., Onzere, C., Potier, M. L., Almagro, V., Martínez, J., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49897-1 · Cited by 34
Altered faecal microbiota on the expression of Th cells responses in the exacerbation of patients with hepatitis E infection
Wu, J., Huang, F., Ling, Z., Liu, S., Liu, J., Fan, J., Yu, J., Wang, W., Jin, X., Meng, Y., et al. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13344 · Cited by 35
The effect of Ganoderma lucidum spore oil in early skin wound healing: interactions of skin microbiota and inflammation
Jiao, C., Xie, Y., Yun, H., Liang, H., He, C., Jiang, A., Wu, Q., & Yang, B. B. (2020) · Aging · doi:10.18632/aging.103412 · Cited by 35
Impacts of gut microbiota alteration on age-related chronic liver diseases
Adhikary, S., Esmeeta, A., Dey, A., Banerjee, A., Saha, B., Gopan, P., Duttaroy, A. K., & Pathak, S. (2023) · Digestive and Liver Disease · doi:10.1016/j.dld.2023.06.017 · Cited by 36
Crucial functions of gut microbiota on gut–liver repair
Wang, Y., Yan, H., Zheng, Q., & Sun, X. (2025) · hLife · doi:10.1016/j.hlife.2025.01.001 · Cited by 39
Hepatitis B: progress in understanding chronicity, the innate immune response, and cccDNA protection
Morikawa, K., Shimazaki, T., Takeda, R., Izumi, T., Umumura, M., & Sakamoto, N. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.08.54 · Cited by 31
Fecal Microbiota Transplantation and Its Potential Therapeutic Uses in Gastrointestinal Disorders
Heath, R. D. (2017) · Northern Clinics of Istanbul · doi:10.14744/nci.2017.10692 · Cited by 32
Modeling hepatitis B virus infection, immunopathology and therapy in mice
Cheng, L., Li, F., Bility, M. T., Murphy, C. M., & Su, L. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.06.012 · Cited by 30
Gut‑liver axis in liver disease: From basic science to clinical treatment (Review)
Wang, J., Wang, X., Zhuo, E., Chen, B., & Chan, S. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13375 · Cited by 33
Interactions Between Gut Microbiota and Hosts and Their Role in Infectious Diseases
Lv, L., Jiang, H., Ren, Y., & Li, L. (2019) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000001 · Cited by 28
Alteration of Gut Microbiota and Its Impact on Immune Response in Patients with Chronic HBV Infection: A Review
Kassa, Y., Million, Y., Gedefie, A., & Moges, F. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s305901 · Cited by 29
Associations between EBV and CMV Seropositivity, Early Exposures, and Gut Microbiota in a Prospective Birth Cohort: A 10-Year Follow-up
Carvalho‐Queiroz, C., Johansson, M. A., Persson, J., Jörtsö, E., Kjerstadius, T., Nilsson, C. A., Saghafian‐Hedengren, S., & Sverremark‐Ekström, E. (2016) · Frontiers in Pediatrics · doi:10.3389/fped.2016.00093 · Cited by 29
Technical Improvement and Application of Hydrodynamic Gene Delivery in Study of Liver Diseases
Huang, M.-J., Sun, R., Huang, Q., & Tian, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00591 · Cited by 26
Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: Molecular mechanisms and therapeutic inventions
Li, Y., Yu, Z., Li, A., & Ren, Z. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i28.3555 · Cited by 28
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
Horng, J.-H., Lin, W.-H., Wu, C.-R., Lin, Y., Wu, L., Chen, D., & Chen, P. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-00662-x · Cited by 26
Self-citation
The effect of pro/synbiotics on postoperative infections in colorectal cancer patients: A systematic review and meta-analysis
Zeng, J., Ji, Y., Liang, B., Zhang, G., Chen, D., Zhu, M., Wu, S., & Kuang, W. (2021) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2021.101370 · Cited by 28
Self-citation
Animal Models for the Study of Hepatitis B Virus Pathobiology and Immunity: Past, Present, and Future
Zhang, X., Wang, X., Wu, M., Ghildyal, R., & Yuan, Z. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.715450 · Cited by 28
Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination
Elias, G., Meysman, P., Bartholomeus, E., Neuter, N. D., Keersmaekers, N., Suls, A., Jansens, H., Souquette, A. H., Reu, H. D., Emonds, M., et al. (2022) · eLife · doi:10.7554/elife.68388 · Cited by 26
Antagonism Between Gut Ruminococcus gnavus and Akkermansia muciniphila Modulates the Progression of Chronic Hepatitis B
Chua, H., Chen, Y., Wu, L., Yang, H., Lin, C.-R., Chen, H., Wu, J., Chang, M., Chen, P., & Ni, Y. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.12.003 · Cited by 23
Self-citation
CD4+ T Cells Play a Critical Role in Microbiota-Maintained Anti-HBV Immunity in a Mouse Model
Wu, T., Li, F., Chen, Y., Wei, H., Tian, Z., Sun, C., & Sun, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00927 · Cited by 22
The Gut–Liver Axis in Pediatric Liver Health and Disease
Rager, S. L., & Zeng, M. Y. (2023) · Microorganisms · doi:10.3390/microorganisms11030597 · Cited by 24
Natural killer cell activation contributes to hepatitis B viral control in a mouse model
Tong, S., Liu, G., Li, M., Li, X., Liu, Q., Peng, H., Li, S., Ren, H., & Yin, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-00387-2 · Cited by 22
Probiotics and their metabolite spermidine enhance IFN-γ+CD4+ T cell immunity to inhibit hepatitis B virus
Wang, T., Fan, Y., Tan, S., Wang, Z., Li, M., Guo, X., Yu, X., Lin, Q., Song, X., Xu, L., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101822 · Cited by 21
Gut Microbiota and the Gut–Liver Axis in Liver Disease: From Chronic Viral Hepatitis to Cirrhosis, Hepatocellular Carcinoma, and Microbiome-Based Therapies
Laivacuma, S., Oblate, O., & Derovs, A. (2025) · Microorganisms · doi:10.3390/microorganisms13051053 · Cited by 21
Gut Microbiota Dysbiosis Strengthens Kupffer Cell-mediated Hepatitis B Virus Persistence through Inducing Endotoxemia in Mice
Zhou, W., Luo, J., Xie, X., Yang, S., Zhu, D., Huang, H., Yang, D., & Liu, J. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00161 · Cited by 20
New insights into hepatitis B virus biology and implications for novel antiviral strategies
Chen, J., Wu, M., Liu, K., Zhang, W., Li, Y., Zhou, X., Bai, L., & Yuan, Z. (2015) · National Science Review · doi:10.1093/nsr/nwv044 · Cited by 20
In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
Ely, A., Singh, P., Smith, T. S., & Arbuthnot, P. B. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.010 · Cited by 19
The Gut Microbiome and Hepatocellular Carcinoma
Akkız, H. (2021) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-021-00748-1 · Cited by 18
Fecal Microbiota Transplantation Alters the Outcome of Hepatitis B Virus Infection in Mice
Wang, J., Zhou, X., Li, X., Guo, W., Zhu, Q., Zhu, B., Lu, Y., Zheng, X., Yang, D., & Wang, B. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.844132 · Cited by 18
How Does Epstein–Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?
Wen, Y., Xu, H., Han, J., Jin, R., & Chen, H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.852066 · Cited by 17

Authors: Chou, H.-H., Chien, W.-H., Wu, L.-L., Cheng, C.-H., Chung, C.-H., Horng, J.-H., Ni, Y.-H., Tseng, H.-T., Wu, D., Lu, X., Wang, H.-Y., Chen, P.-J., & Chen, D.-S.
Affiliations: National Taiwan University (TW)
Chinese Academy of Sciences (CN)
ORCID: Wu, Li-Ling
Ni, Yen-Hsuan
Lu, Xuemei
Wang, Hurng-Yi
Chen, Pei-Jer
Chen, Ding-Shinn
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2015-02-02
Volume: 112
Issue: 7
Pages: 2175-2180
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1424775112
PMC: PMC4343154
OpenAlex: W2143865587
Cited by: 211
References: 34
Citations by year: 2026: 5 · 2025: 18 · 2024: 19 · 2023: 18 · 2022: 18 · 2021: 24 · 2020: 31 · 2019: 22 · 2018: 14 · 2017: 21 · 2016: 10 · 2015: 11
FWCI: 14.65
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: hepatitis B virus, viral clearance, age-related immunity, gut microbiota, TLR4, antibiotic-induced microbiota depletion, liver immunity, immune tolerance, C3H/HeN mice, C3H/HeJ mice
MeSH terms: Animals, Hepatitis B, Humans, Intestines, Mice, Inbred BALB C, Mice, Inbred NOD, Mice, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks